Erwin De Genst

3.7k citations

41 papers · 3.0k indexed · 1 hit paper · h-index 26

Impact in

Radiology, Nuclear Medicine and Imaging top 1%
- Monoclonal and Polyclonal Antibodies Research
Endocrinology top 2%
- Escherichia coli research studies

Papers in

Endocrinology 4
Radiology, Nuclear Medicine and Imaging 12
- Monoclonal and Polyclonal Antibodies Research 12

Co-authors: Serge Muyldermans Lode Wyns Remy Loris Christopher M. Dobson Katja Conrath Jörg Kinne Klaas Decanniere Karen Silence
Journals: Scientific Reports (3 papers)Journal of Biological Chemistry (3 papers)Journal of Molecular Biology (3 papers)Biochemistry (3 papers)Molecular Microbiology (2 papers)
Partner nations: United Kingdom Belgium United States

In The Last Decade

Erwin De Genst

41 papers receiving 2.9k citations

Hit Papers

align trajectories log scale

Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies 2006 · 514 citations

Peers

Countries citing papers authored by Erwin De Genst

Since Specialization

Citations

This map shows the geographic impact of Erwin De Genst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwin De Genst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwin De Genst more than expected).

Fields of papers citing papers by Erwin De Genst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erwin De Genst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwin De Genst. The network helps show where Erwin De Genst may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Erwin De Genst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erwin De Genst Line = papers co-authored together Erwin De Genst links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model npj Parkinson s Disease ·O. A. Shchelokova, Irina Poyda, David Butler, Erwin De Genst, Christopher M. Dobson, Anne Messer, Jeffrey H. Kordower	2018	74
2	Silk micrococoons for protein stabilisation and molecular encapsulation Nature Communications ·Ulyana Shimanovich, Francesco Simone Ruggeri, Erwin De Genst, Jozef Adamčík, Teresa P. Barros, David Porter, Thomas Müller, Raffaele Mezzenga, Christopher M. Dobson, Fritz Vollrath, Chris Holland, Tuomas P. J. Knowles	2017	100
3	Nanobodies raised against monomeric ɑ-synuclein inhibit fibril formation and destabilize toxic oligomeric species BMC Biology ·Marija Iljina, Liu Hong, Mathew H. Horrocks, Marthe H. R. Ludtmann, Minee L. Choi, Craig D. Hughes, Francesco Simone Ruggeri, Tim Guilliams, Alexander K. Buell, Ji‐Eun Lee, Sonia Gandhi, Steven F. Lee, Clare Bryant, Michele Vendruscolo, Tuomas P. J. Knowles, Christopher M. Dobson, Erwin De Genst, David Klenerman	2017	59
4	The Significance of the Location of Mutations for the Native-State Dynamics of Human Lysozyme Biophysical Journal ·Minkoo Ahn, Christine L. Hagan, М Д'эррико, Erwin De Genst, Aristofane , John Christodoulou, Anne Dhulesia, Mireille Dumoulin, Carol V. Robinson, Christopher M. Dobson, Janet R. Kumita	2016	18
5	Antibodies and protein misfolding: From structural research tools to therapeutic strategies Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics ·Erwin De Genst, Anne Messer, Christopher M. Dobson	2014	59
6	Differential nuclear localization of complexes may underlie in vivo intrabody efficacy in Huntington's disease Protein Engineering Design and Selection ·Daniel Butler, Jonas-David Ziegler, Erwin De Genst, Anne Messer	2014	9
7	Nanobodies Raised against Monomeric α-Synuclein Distinguish between Fibrils at Different Maturation Stages Journal of Molecular Biology ·Tim Guilliams, Farah El-Turk, Alexander K. Buell, Elizabeth O’Day, Francesco A. Aprile, Elin K. Esbjörner, Michele Vendruscolo, Nunilo Cremades, Els Pardon, Lode Wyns, Mark E. Welland, Jan Steyaert, John Christodoulou, Christopher M. Dobson, Erwin De Genst	2013	89
8	Analysis of the Native Structure, Stability and Aggregation of Biotinylated Human Lysozyme PLoS ONE ·Minkoo Ahn, Erwin De Genst, Gabriele S. Kaminski Schierle, Miklós Erdélyi, Clemens F. Kaminski, Christopher M. Dobson, Janet R. Kumita	2012	26
9	Nanobodies as Structural Probes of Protein Misfolding and Fibril Formation Methods in molecular biology ·Erwin De Genst, Christopher M. Dobson	2012	16
10	A non-natural variant of human lysozyme (I59T) mimics the in vitro behaviour of the I56T variant that is responsible for a form of familial amyloidosis Protein Engineering Design and Selection ·Christine L. Hagan, Russell J. Johnson, Anne Dhulesia, Mireille Dumoulin, Hou Jianwei, Erwin De Genst, John Christodoulou, Carol V. Robinson, Christopher M. Dobson, Janet R. Kumita	2010	17
11	Camelid immunoglobulins and nanobody technology Veterinary Immunology and Immunopathology ·Serge Muyldermans, Toya Nath Baral, Vic Godlewski, Patrick De Baetselier, Erwin De Genst, Jörg Kinne, Heinrich Leonhardt, Stefan Magez, Viet Khong Nguyen, Hilde Revets, Ulrich Rothbauer, Benoı̂t Stijlemans, С. В. Тиллиб, U. Wernery, L. Wyns, Samantha Ha DiMuzio, Dirk Saerens	2008	421
12	Wnt3a binds to several sFRPs in the nanomolar range Biochemical and Biophysical Research Communications ·E. Malcherek, Mourad Métioui, Erik Willems, Marijke Hendrickx, Erwin De Genst, Luc Leyns	2007	90
13	Antibody repertoire development in camelids Developmental & Comparative Immunology ·Erwin De Genst, Dirk Saerens, Serge Muyldermans, Katja Conrath	2005	144
14	Molecular Basis of Gyrase Poisoning by the Addiction Toxin CcdB Journal of Molecular Biology ·Minh‐Hoa Dao‐Thi, Laurence Van Melderen, Erwin De Genst, Hassan Afif, L. Buts, Lode Wyns, Remy Loris	2005	116
15	Receptor binding studies disclose a novel class of high‐affinity inhibitors of the Escherichia coli FimH adhesin Molecular Microbiology ·Julie Bouckaert, Jenny Berglund, Mark A. Schembri, Erwin De Genst, Lieve Cools, Manfred Wuhrer, Chia‐Suei Hung, Jerome S. Pinkner, Rikard Slättegård, Anton V. Zavialov, Devapriya Choudhury, Solomon Langermann, Scott J. Hultgren, Lode Wyns, Per Klemm, Stefan Oscarson, Stefan D. Knight, Henri De Greve	2004	368
16	Crystallization of CcdB in complex with a GyrA fragment Acta Crystallographica Section D Biological Crystallography ·Déborah Vieille, Laurence Van Melderen, Erwin De Genst, L. Buts, Б.Т. Алпеисова, Lode Wyns, Remy Loris	2004	20
17	Solving the phase problem for carbohydrate-binding proteins using selenium derivatives of their ligands: a case study involving the bacterial F17-G adhesin Acta Crystallographica Section D Biological Crystallography ·L. Buts, Remy Loris, Erwin De Genst, Stefan Oscarson, Martina Lahmann, Joris Messens, Elke Brosens, Lode Wyns, Henri De Greve, Julie Bouckaert	2003	18
18	The fimbrial adhesin F17‐G of enterotoxigenic Escherichia coli has an immunoglobulin‐like lectin domain that binds N‐acetylglucosamine Molecular Microbiology ·L. Buts, Julie Bouckaert, Erwin De Genst, Remy Loris, Stefan Oscarson, Martina Lahmann, Joris Messens, Elke Brosens, Lode Wyns, Henri De Greve	2003	81
19	Kinetic and Affinity Predictions of a Protein-Protein Interaction Using Multivariate Experimental Design Journal of Biological Chemistry ·Erwin De Genst, Manuel Meijide-Vecino, Klaas Decanniere, Serge Muyldermans, Karl Andersson	2002	39
20	Camel single-domain antibody inhibits enzyme by mimicking carbohydrate substrate Proteins Structure Function and Bioinformatics ·Thomas R. Transue, Erwin De Genst, Mehdi Arbabi Ghahroudi, Lode Wyns, Serge Muyldermans	1998	89

About Erwin De Genst

Erwin De Genst is a scholar working on Endocrinology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Molecular Medicine and Neurology, having authored 41 papers that have together received 3.0k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (13 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Protein Structure and Dynamics (8 papers), Enzyme Structure and Function (6 papers), Parkinson's Disease Mechanisms and Treatments (5 papers), Protein purification and stability (5 papers), Neurological disorders and treatments (5 papers) and Genetic Neurodegenerative Diseases (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.2k citations), Endocrinology (257 citations), Molecular Biology (1.8k citations), Molecular Medicine (119 citations) and Immunology (462 citations). Erwin De Genst has collaborated with scholars based in United Kingdom, Belgium and United States. Frequent co-authors include Serge Muyldermans, Lode Wyns, Remy Loris, Christopher M. Dobson, Katja Conrath, Jörg Kinne, Klaas Decanniere, Karen Silence, Dirk Saerens and Anne Messer. Their work appears in journals such as Scientific Reports, Journal of Biological Chemistry, Journal of Molecular Biology, Biochemistry and Molecular Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact